Clover Health Investments (CLOV) Accumulated Expenses (2019 - 2026)

Clover Health Investments has reported Accumulated Expenses for 8 years, with the latest figure at $31.2 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 2.32% year-over-year to $31.2 million; the trailing twelve-month figure through Mar 2026 stood at $31.2 million (up 2.32% YoY), and the FY2025 full-year result was $16.0 million, down 15.99% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $31.2 million, up from $16.0 million in the prior quarter.
• The five-year high for Accumulated Expenses was $35.3 million in Q3 2024, with the low at $11.6 million in Q1 2022.
• Historically, Accumulated Expenses has averaged $23.6 million across 5 years, with a median of $24.0 million in 2022.
• Annual changes were most pronounced in 2023 — Accumulated Expenses soared 161.48% — and 2025, when it slumped 51.41%.
• Clover Health Investments' Accumulated Expenses stood at $24.0 million in 2022, then declined by 12.57% to $21.0 million in 2023, then dropped by 8.88% to $19.1 million in 2024, then declined by 15.99% to $16.0 million in 2025, then jumped by 94.73% to $31.2 million in 2026.
• The last three Accumulated Expenses figures came in at $31.2 million (Q1 2026), $16.0 million (Q4 2025), and $17.2 million (Q3 2025), per Business Quant data.